세계의 기도 스텐트 시장 : 예측(2025-2030년)

The global airway stent market is expected to grow from USD 141.017 million in 2025 to USD 181.331 million in 2030, at a CAGR of 5.16%.

The global airway stent market is projected to experience significant growth from 2025 to 2030, driven by the rising prevalence of respiratory chronic disorders and the increasing adoption of minimally invasive procedures. Airway stents, used to manage benign and malignant lesions in the central airway through techniques like mechanical debridement, laser resection, photodynamic therapy, and endobronchial brachytherapy, are critical for treating conditions such as lung cancer, tuberculosis, and chronic obstructive pulmonary disease (COPD). The market is propelled by advancements in biodegradable and drug-eluting stents, rising pollution levels, and high tobacco smoking rates. North America leads the market, while Asia-Pacific shows strong growth potential. Challenges include complications associated with stent implantation.

Market Drivers

Rising Prevalence of Respiratory Disorders

The increasing incidence of chronic respiratory conditions, including lung cancer, tuberculosis, and COPD, is a primary driver of the airway stent market. Rising pollution levels and the persistent high prevalence of tobacco smoking globally contribute to the growing burden of these diseases. Airway stents are essential for maintaining airway patency in patients with obstructive lesions, supporting both therapeutic and palliative care. The escalating need for effective interventions to manage these conditions is driving demand for advanced stent technologies.

Preference for Minimally Invasive Procedures

The growing preference for minimally invasive procedures, which offer reduced recovery times and lower complication risks compared to traditional surgeries, is boosting the adoption of airway stents. Techniques like endoscopic stent placement enable precise treatment of airway obstructions, improving patient outcomes. This trend is particularly prominent in hospitals and ambulatory surgical centers, where minimally invasive approaches are increasingly integrated into standard care protocols, further fueling market growth.

Advancements in Stent Technology

Innovations in biodegradable and drug-eluting airway stents are enhancing market growth. Biodegradable stents eliminate the need for removal procedures, reducing long-term complications, while drug-eluting stents deliver targeted therapies to prevent restenosis and inflammation. These advancements improve patient safety and treatment efficacy, driving adoption across clinical settings and supporting the market's expansion.

Market Restraints

The airway stent market faces challenges due to complications associated with stent implantation, such as migration, infection, or granulation tissue formation, which can deter adoption and increase healthcare costs. The high cost of advanced stents and the need for skilled professionals to perform endoscopic procedures also pose barriers, particularly in developing regions with limited healthcare infrastructure. Addressing these challenges through improved stent designs and training programs will be critical for sustained market growth.

Market Segmentation

By Material Type

The market is segmented into metal, silicone, and hybrid stents. Silicone stents dominate due to their flexibility and biocompatibility, making them suitable for long-term use in benign conditions. Metal stents are preferred for malignant obstructions due to their durability, while hybrid stents, combining metal and silicone properties, are gaining traction for their versatility in complex cases.

By End-User

The market is divided into hospitals and clinics, and ambulatory surgical centers. Hospitals and clinics hold the largest share, driven by their advanced infrastructure and high volume of respiratory procedures. Ambulatory surgical centers are a growing segment, supported by the increasing adoption of minimally invasive techniques in outpatient settings.

By Geography

The market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America leads due to its advanced healthcare systems, high prevalence of respiratory disorders, and early adoption of innovative stent technologies. Asia-Pacific is expected to grow rapidly, driven by increasing healthcare investments, rising pollution levels, and growing awareness of respiratory health in countries like China and India. Europe, South America, and the Middle East and Africa are emerging markets, supported by improving healthcare infrastructure.

The airway stent market is set for robust growth from 2025 to 2030, driven by the rising prevalence of respiratory disorders, preference for minimally invasive procedures, and advancements in biodegradable and drug-eluting stents. Despite challenges from implantation complications and high costs, the market's outlook is positive, particularly in North America and Asia-Pacific. Industry players must focus on innovative stent designs, cost-effective solutions, and clinician training to capitalize on the growing demand for airway stents in managing chronic respiratory conditions.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2020 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Different segments covered under the global airway stent market report are as below:

By Material Type

• Metal
• Silicone
• Hybrid

By End-User

• Hospitals and Clinics
• Ambulatory Surgical Centers

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL AIRWAY STENT MARKET BY MATERIAL TYPE

• 5.1. Introduction
• 5.2. Metal
• 5.3. Silicone
• 5.4. Hybrid

6. GLOBAL AIRWAY STENT MARKET BY END-USER

• 6.1. Introduction
• 6.2. Hospitals and Clinics
• 6.3. Ambulatory Surgical Centers

7. GLOBAL AIRWAY STENT MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. USA
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. South America
  • 7.3.1. Brazil
  • 7.3.2. Argentina
  • 7.3.3. Others
• 7.4. Europe
  • 7.4.1. United Kingdom
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Spain
  • 7.4.5. Others
• 7.5. Middle East & Africa
  • 7.5.1. Saudi Arabia
  • 7.5.2. UAE
  • 7.5.3. Israel
  • 7.5.4. Others
• 7.6. Asia Pacific
  • 7.6.1. Japan
  • 7.6.2. China
  • 7.6.3. India
  • 7.6.4. South Korea
  • 7.6.5. Indonesia
  • 7.6.6. Thailand
  • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Market Share Analysis
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Competitive Dashboard

9. COMPANY PROFILES

• 9.1. Boston Scientific Corporation
• 9.2. Novatech SA
• 9.3. Cook Medical
• 9.4. MICRO-TECH Europe GmbH
• 9.5. Medtronic
• 9.6. Cook Medical
• 9.7. MICRO-TECH (Nanjing) Co., Ltd.
• 9.8. Merit Medical Systems

10. RESEARCH METHODOLOGY